SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-349953
Filing Date
2012-08-10
Accepted
2012-08-10 16:01:07
Documents
9
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d330972d10q.htm 10-Q 448427
2 EX-31.1 d330972dex311.htm EX-31.1 9966
3 EX-32.1 d330972dex321.htm EX-32.1 4893
  Complete submission text file 0001193125-12-349953.txt   5202950

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ljpc-20120630.xml EX-101.INS 785346
5 XBRL TAXONOMY EXTENSION SCHEMA ljpc-20120630.xsd EX-101.SCH 55911
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ljpc-20120630_cal.xml EX-101.CAL 31344
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ljpc-20120630_def.xml EX-101.DEF 221581
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ljpc-20120630_lab.xml EX-101.LAB 366982
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ljpc-20120630_pre.xml EX-101.PRE 290921
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 121024613
SIC: 2836 Biological Products, (No Diagnostic Substances)